Global cord blood announces nhc policy update

Hong kong, jan. 5, 2021 /prnewswire/ -- global cord blood corporation (nyse: co) (the "company"), china's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today reported that china's national health...
CO Ratings Summary
CO Quant Ranking